Unit 10
Patients suffering from some sort of respiratory distress after a postoperative time are entitled to receive Hyperinflation Therapy, or commonly known as Lung Expansion Therapy. Targeting the thoracic region, this therapy involves giving greater volume of oxygen to a patient to prevent atelectasis, which is, collapsed alveoli. Surfactant deals with a big part of hyperinflation therapy because surfactant is what reduces the tension of alveoli and keeps them inflated. If a patient is unable to fill their alveoli with air on their own, surfactant will not be released and cause the alveoli to collapse. In Cystic Fibrosis patients , the mucus creates a blockage in the airways which causes the patient to go into Atelectasis.
There are two
Patients suffering from some sort of respiratory distress after a postoperative time are entitled to receive Hyperinflation Therapy, or commonly known as Lung Expansion Therapy. Targeting the thoracic region, this therapy involves giving greater volume of oxygen to a patient to prevent atelectasis, which is, collapsed alveoli. Surfactant deals with a big part of hyperinflation therapy because surfactant is what reduces the tension of alveoli and keeps them inflated. If a patient is unable to fill their alveoli with air on their own, surfactant will not be released and cause the alveoli to collapse. In Cystic Fibrosis patients , the mucus creates a blockage in the airways which causes the patient to go into Atelectasis.
There are two